{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:54:38Z","timestamp":1781304878764,"version":"3.54.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Previous studies have reported the association of an insertion\/deletion (Ins\/Del) polymorphism (rs145204276 AGGCA\/-) in the promoter region of growth arrest-specific 5 (GAS5) with the risk of cancer, such as breast cancer, gastric cancer, and hepatocellular carcinoma. However, the results are still controversial. We aimed to clarify the association of GAS5 rs145204276 polymorphism with cancer risk by meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang, and Cochrane Library were searched for studies concerning GAS5 and cancer published up to November 25, 2019. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate cancer risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 12 case\u2013control studies with 8729 cases and 10,807 controls were included in this meta-analysis. We found that the GAS5 rs145204276 polymorphism was not significantly associated with cancer risk (Del vs Ins: OR\u200a=\u200a0.96, 95% CI: 0.81\u20131.13; Del\/Del vs Ins\/Ins: OR\u200a=\u200a1.00, 95% CI: 0.70\u20131.43; Ins\/Del vs Ins\/Ins: OR\u200a=\u200a0.92, 95% CI: 0.78\u20131.08; Ins\/Del and Del\/Del vs Ins\/Ins: OR\u200a=\u200a0.93, 95% CI: 0.76\u20131.13; Del\/Del vs Ins\/Del and Ins\/Ins: OR\u200a=\u200a1.04, 95% CI: 0.78\u20131.38). In the stratified analyses, significant effects on gastric cancer were found (Del vs Ins: OR\u200a=\u200a0.79, 95% CI: 0.72\u20130.86; Del\/Del vs Ins\/Ins: OR\u200a=\u200a0.65, 95% CI: 0.52\u20130.82; Ins\/Del vs Ins\/Ins: OR\u200a=\u200a0.76, 95% CI: 0.68\u20130.86; Ins\/Del + Del\/Del vs Ins\/Ins: OR\u200a=\u200a0.74, 95% CI: 0.66\u20130.83; Del\/Del vs Ins\/Ins + Ins\/Del: OR\u200a=\u200a0.74, 95% CI: 0.59\u20130.91).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our meta-analysis showed that GAS5 rs145204276 polymorphisms were not related to overall cancer risk. However, the GAS5 rs145204276 polymorphism may be a protective factor for gastric cancer in the stratification analyses.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027415","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T22:25:09Z","timestamp":1637706309000},"page":"e27415","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Growth arrest-specific 5 (GAS5) insertion\/deletion polymorphism and cancer susceptibility in Asian populations"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3644-2594","authenticated-orcid":false,"given":"Gan","family":"Gao","sequence":"first","affiliation":[{"name":"Liuzhou Maternity and Child Healthcare Hospital, Affiliated Maternity Hospital and Affiliated Children's Hospital of Guangxi University of Science and Technology, LiuZhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Liu","sequence":"additional","affiliation":[{"name":"Liuzhou Maternity and Child Healthcare Hospital, Affiliated Maternity Hospital and Affiliated Children's Hospital of Guangxi University of Science and Technology, LiuZhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Li","sequence":"additional","affiliation":[{"name":"Liuzhou Maternity and Child Healthcare Hospital, Affiliated Maternity Hospital and Affiliated Children's Hospital of Guangxi University of Science and Technology, LiuZhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Laboratory, The First Affiliated Hospital of Guangxi University of Science and Technology, LiuZhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yang","sequence":"additional","affiliation":[{"name":"Liuzhou Maternity and Child Healthcare Hospital, Affiliated Maternity Hospital and Affiliated Children's Hospital of Guangxi University of Science and Technology, LiuZhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixu","family":"Qin","sequence":"additional","affiliation":[{"name":"Liuzhou Maternity and Child Healthcare Hospital, Affiliated Maternity Hospital and Affiliated Children's Hospital of Guangxi University of Science and Technology, LiuZhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the Global Burden of Disease Study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e17854","DOI":"10.1097\/MD.0000000000017854","article-title":"Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"116675","DOI":"10.1016\/j.lfs.2019.116675","article-title":"Functional variants of autophagy-related genes are associated with the development of hepatocellular carcinoma","volume":"235","author":"Shen","year":"2019","journal-title":"Life Sci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"116918","DOI":"10.1016\/j.lfs.2019.116918","article-title":"FAL1: a critical oncogenic long non-coding RNA in human cancers","volume":"236","author":"Lv","year":"2019","journal-title":"Life Sci"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/bib\/bbx042","article-title":"Long noncoding RNA: a crosslink in biological regulatory network","volume":"19","author":"Zhang","year":"2018","journal-title":"Brief Bioinform"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12020-019-02015-7","article-title":"Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus","volume":"65","author":"Zhang","year":"2019","journal-title":"Endocrine"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.21873\/anticanres.13564","article-title":"Long noncoding RNA, ANRIL, regulates the proliferation of head and neck squamous cell carcinoma","volume":"39","author":"Matsunaga","year":"2019","journal-title":"Anticancer Res"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"116597","DOI":"10.1016\/j.lfs.2019.116597","article-title":"LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384\/WEE1 axis","volume":"232","author":"Wang","year":"2019","journal-title":"Life Sci"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/bab.1764","article-title":"Circulating long non-coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non-small cell lung cancer","volume":"66","author":"Kamel","year":"2019","journal-title":"Biotechnol Appl Biochem"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.2147\/OTT.S221305","article-title":"Novel tumor suppressor lncRNA growth arrest-specific 5 (GAS5) in human cancer","volume":"12","author":"Yu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"R12-20250504","first-page":"46","article-title":"The growth-arrest-specific (GAS)-5 long non-coding RNA: a fascinating lncRNA widely expressed in cancers","volume":"5","author":"Goustin","year":"2019","journal-title":"Noncoding RNA"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.7150\/ijms.38080","article-title":"Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics","volume":"16","author":"Lin","year":"2019","journal-title":"Int J Med Sci"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.clbc.2018.11.006","article-title":"A genetic variant of rs145204276 in the promoter region of long noncoding RNA GAS5 is associated with a reduced risk of breast cancer","volume":"19","author":"Tang","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09674845.2018.1530581","article-title":"A functional genetic variant in GAS5 lncRNA (rs145204276) modulates p27(Kip1) expression and confers risk for gastric cancer","volume":"76","author":"Aminian","year":"2019","journal-title":"Br J Biomed Sci"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.clinre.2018.01.006","article-title":"Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer","volume":"42","author":"Li","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1089\/dna.2018.4215","article-title":"LncRNA GAS5 indel genetic polymorphism contributes to glioma risk through interfering binding of transcriptional factor TFAP2A","volume":"37","author":"Yuan","year":"2018","journal-title":"DNA Cell Biol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbo.2018.03.001","article-title":"A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma","volume":"12","author":"Xu","year":"2018","journal-title":"J Bone Oncol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15403\/jgld.2014.1121.271.qjl","article-title":"The variant rs145204276 of GAS5 is associated with the development and prognosis of gastric cancer","volume":"27","author":"Li","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"91025","DOI":"10.18632\/oncotarget.19955","article-title":"Genetic variation of lncRNA GAS5 contributes to the development of lung cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"83727","DOI":"10.18632\/oncotarget.13384","article-title":"LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer","volume":"7","author":"Zheng","year":"2016","journal-title":"Oncotarget"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/carcin\/bgv099","article-title":"Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma","volume":"36","author":"Tao","year":"2015","journal-title":"Carcinogenesis"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"424","DOI":"10.21037\/tcr.2017.03.50","article-title":"A novel functional indel polymorphism within long non-coding RNAs growth arrest specific 5 conferred risk for cervical squamous cell carcinoma in Chinese Han populations","volume":"6","author":"Zhu","year":"2017","journal-title":"Transl Cancer Res"},{"key":"R24-20250504","first-page":"11767","article-title":"Functional indel polymorphism within lncRNA GAS5 and colorectal carcinoma risk","volume":"9","author":"Zhu","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"key":"R25-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11101524","article-title":"LncRNAs as chromatin regulators in cancer: from molecular function to clinical potential","volume":"11","author":"Begolli","year":"2019","journal-title":"Cancers"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.2147\/CMAR.S189052","article-title":"The role of long non-coding RNA GAS5 in cancers","volume":"11","author":"Ji","year":"2019","journal-title":"Cancer Manag Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"18946","DOI":"10.1002\/jcb.29215","article-title":"Association and in silico investigations of miR-302c insertion\/deletion variant as a novel biomarker with susceptibility to gastric cancer","volume":"120","author":"Raad","year":"2019","journal-title":"J Cell Biochem"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"197","DOI":"10.11604\/pamj.2019.32.197.15129","article-title":"Angiotensin-converting enzyme insertion\/deletion gene polymorphisms and the risk of glioma in an Algerian population","volume":"32","author":"Benenemissi","year":"2019","journal-title":"Pan Afr Med J"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000433499","article-title":"GAS5 inhibits gastric cancer cell proliferation partly by modulating CDK6","volume":"38","author":"Guo","year":"2015","journal-title":"Oncol Res Treat"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1002\/jcb.26145","article-title":"Long noncoding RNA GAS5 suppresses cell growth and epithelial-mesenchymal transition in osteosarcoma by regulating the miR-221\/ARHI pathway","volume":"118","author":"Ye","year":"2017","journal-title":"J Cell Biochem"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:38:47Z","timestamp":1746333527000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027415"}},"subtitle":["A meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":30,"journal-issue":{"issue":"41","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027415","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"2021-02-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}